SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HELIX BIOPHARMA (HBP:TSE)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: trustmanic who wrote (19)4/4/1997 9:18:00 PM
From: burner   of 193
 
Hi George,
I spoke with Terry Owen today and asked if they had heard from you and was told that you stopped by. What did you think of the operation?
Terry has been buying stock lately, I don't know how much, but I'm sure we can see on the insider trading reports. I intend to pick up some more at these levels.
This company has no long term debt other than a small loan with one of the directors. Insidersown 4.4 million shares which amounts to around 33% of the o/s shares.
The company generates revenue from its DNA lab and product sales. They have at least 4 products already in the approval process before the Health Protection Branch. It has a decent operating margin and a good price to cash flow ratio. With an improved presence among brokerage firms and analysts, Which Barnes and their new Public Relations person this company has got nowhere to but up. You got in at a good price; tuck it away and forget about it for a while.
Welcome aboard and good luck with your investment strategies.
Dan
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext